This kind of cancer involves a unique range of genetic changes. Different cells in a tumour may undergo different genetic changes. They may be congenital, caused by mutations, or resulting from DNA damage. Genetic changes affect three main gene types – proto-oncogenes, tumour suppressors, and genes for DNA recovery.
Breast cancer is most frequently an adenocarcinoma. It forms in epithelial cells responsible for the production of fluids and mucus.
Breast cancer is the most common cancer type affecting women and makes up 26.5% of all malignant diseases. The disease is less common among men. The men–women ratio is around 1:100. Morbidity rates are high and tend to go up by an annual average of 1.8%. Among patients of over 35, breast cancer age-specific morbidity rate increases with age and reaches its peak at the age of 65-69. 70.3% of the patients have been diagnosed with initial (first or second) stage of the disease. 25.4% of them are at the third or fourth stage. There is no specific information about the rest. Breast cancer morbidity rates in Bulgaria are lower than the average European ones.
Possible symptoms indicating breast cancer:
Usually, during regular prophylactic examinations and monthly self-examination (palpate your breasts each month: while having a shower, looking at the mirror, or lying), breast cancer is found at an early stage, which is the best guarantee for successful treatment.
The presence of the symptoms below suggest the disease is at a more advanced stage and an immediate consultation with a specialist is imperative.
Very often, the presence of lumps or thickening do not necessarily indicate the presence of cancer; this may be a medical condition different from cancer. Finding these should not lead to fear or panic, but you must immediately consult a medical doctor.
In most breast cancer cases, it is necessary to perform surgical treatment of the primary tumour in order to remove the cancer to the greatest possible extent. Conventional therapy also includes chemotherapy and/or radiation therapy (radiotherapy).
During therapy, the body gets blocked by a huge amount of toxins. The severe intoxication of the body following chemotherapy leads to a total block of the vital energy and the organism becomes congested with toxins, so microparasites and fungi are free to gain strength and multiply, which in its turn creates prerequisites for new tumour formations. The toxins accumulated in the body block the immune system’s normal function, the organs and systems are not in a position to perform natural detoxification.
Patients suffering from an oncological disease need urgent high-quality antioxidant. Antioxidants (anti-oxidant) have a favourable and relieving effect on the human body. Not only do they destroy free radicals, but they also improve the body’s physiological functions by protecting it from viruses, bacteria, and toxic substances and boost the immune system.
Vitaceptin® is a powerful antioxidant created to work in a few directions and to successfully deal with the negative effects on the body caused by radiation and chemotherapy. It effectively stimulates the liver’s main function to detoxify the body, purging it of accumulated toxins after radiation and chemotherapy.
The main function of Vitaceptin® is to effectively assist the recovery of the body’s immune system which has been damaged by radiation therapy and chemotherapy. The Vitaceptin® antioxdant has been shown to have a positive effect on oncological diseases. It plays a role in prevention through a number of mechanisms and increases the anti-tumour functions of the healthy cells of the affected patient.
Vitaceptin® helps the body recover its normal protective functions and enables it to continue fighting in the most effective way.